BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26325526)

  • 1. Patterns of care, associations and outcomes of chemotherapy for uterine serous carcinoma: analysis of the National Cancer Database.
    Rauh-Hain JA; Diver E; Meyer LA; Clemmer J; Lu KH; Del Carmen MG; Schorge JO
    Gynecol Oncol; 2015 Oct; 139(1):77-83. PubMed ID: 26325526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of care, predictors and outcomes of chemotherapy for uterine carcinosarcoma: a National Cancer Database analysis.
    Rauh-Hain JA; Starbuck KD; Meyer LA; Clemmer J; Schorge JO; Lu KH; Del Carmen MG
    Gynecol Oncol; 2015 Oct; 139(1):84-9. PubMed ID: 26307402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Treatment of Uterine Serous Cancer in the Medicare Population.
    Rauh-Hain JA; Connor SC; Clemmer JT; Foley OW; Clark RM; Hall TR; Boruta DM; Schorge JO; del Carmen MG
    Int J Gynecol Cancer; 2015 Jul; 25(6):1023-30. PubMed ID: 25914960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.
    Alvarez Secord A; Havrilesky LJ; Bae-Jump V; Chin J; Calingaert B; Bland A; Rutledge TL; Berchuck A; Clarke-Pearson DL; Gehrig PA
    Gynecol Oncol; 2007 Nov; 107(2):285-91. PubMed ID: 17688923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Cancer Database Report of Lymphadenectomy Trends in Endometrial Cancer.
    Cripe J; Handorf E; Brown J; Jain A; Rubin S; Mantia-Smaldone G
    Int J Gynecol Cancer; 2017 Sep; 27(7):1408-1415. PubMed ID: 28525495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of Care, Predictors, and Outcomes of Adjuvant Therapy for Early- and Advanced-Stage Uterine Clear Cell Carcinoma: A Population-Based Analysis.
    Gockley AA; Rauh-Hain JA; Anders AM; Meyer LA; Clemmer J; Lu KH; Clark RM; Schorge JO; del Carmen MG
    Int J Gynecol Cancer; 2016 May; 26(4):697-704. PubMed ID: 26825834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of management on the prognosis of pure uterine papillary serous cancer - a Taiwanese Gynecologic Oncology Group (TGOG) study.
    Huang CY; Tang YH; Chiang YC; Wang KL; Fu HC; Ke YM; Lau HY; Hsu KF; Wu CH; Cheng WF
    Gynecol Oncol; 2014 May; 133(2):221-8. PubMed ID: 24556064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
    Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
    Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer.
    Kiess AP; Damast S; Makker V; Kollmeier MA; Gardner GJ; Aghajanian C; Abu-Rustum NR; Barakat RR; Alektiar KM
    Gynecol Oncol; 2012 Nov; 127(2):321-5. PubMed ID: 22850412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of adjuvant chemotherapy and pelvic radiation on pattern of recurrence and outcome in stage I non-invasive uterine papillary serous carcinoma. A multi-institution study.
    Mahdi H; Elshaikh MA; DeBenardo R; Munkarah A; Isrow D; Singh S; Waggoner S; Ali-Fehmi R; Morris RT; Harding J; Moslemi-Kebria M
    Gynecol Oncol; 2015 May; 137(2):239-44. PubMed ID: 25641568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant vaginal brachytherapy and chemotherapy versus pelvic radiotherapy in early-stage endometrial cancer: Outcomes by risk factors.
    Tatebe K; Hasan Y; Son CH
    Gynecol Oncol; 2019 Dec; 155(3):429-435. PubMed ID: 31610885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of care, predictors and outcomes of chemotherapy for ovarian carcinosarcoma: A National Cancer Database analysis.
    Rauh-Hain JA; Gonzalez R; Bregar AJ; Clemmer J; Hernández-Blanquisett A; Clark RM; Schorge JO; Del Carmen MG
    Gynecol Oncol; 2016 Jul; 142(1):38-43. PubMed ID: 27107722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of adjuvant therapies and their impact on survival for women with stage IIIC endometrial adenocarcinoma.
    Wong AT; Rineer J; Lee YC; Schwartz D; Safdieh J; Weiner J; Choi K; Schreiber D
    Gynecol Oncol; 2016 Sep; 142(3):514-9. PubMed ID: 27421751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of adjuvant chemotherapy versus whole abdominopelvic radiation on the survival of patients with advanced stage uterine papillary serous carcinoma.
    Hamilton CA; Cheung MK; Osann K; Balzer B; Berman ML; Husain A; Teng NN; Kapp DS; Chan JK
    Gynecol Oncol; 2006 Nov; 103(2):679-83. PubMed ID: 16793126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma.
    Hamilton CA; Liou WS; Osann K; Berman ML; Husain A; Teng NN; Kapp DS; Chan JK
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):839-44. PubMed ID: 16199314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of radiation therapy for early-stage uterine papillary serous carcinoma.
    Cham S; Huang Y; Tergas AI; Hou JY; Burke WM; Deutsch I; Ananth CV; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2017 May; 145(2):269-276. PubMed ID: 28343693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma.
    Low JS; Wong EH; Tan HS; Yap SP; Chua EJ; Sethi VK; Soh LT; Low J; Tay EH; Chew SH
    Gynecol Oncol; 2005 Apr; 97(1):171-7. PubMed ID: 15790454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant treatment for patients with FIGO stage I uterine serous carcinoma confined to the endometrium.
    Nasioudis D; Roy AG; Ko EM; Cory L; Giuntoli Ii RL; Haggerty AF; Kim SH; Morgan MA; Latif NA
    Int J Gynecol Cancer; 2020 Aug; 30(8):1089-1094. PubMed ID: 32675056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant docetaxel and carboplatin chemotherapy administered alone or with radiotherapy in a "sandwich" protocol in patients with advanced endometrial cancer: a single-institution experience.
    Lan C; Huang X; Cao X; Huang H; Feng Y; Huang Y; Liu J
    Expert Opin Pharmacother; 2013 Apr; 14(5):535-42. PubMed ID: 23480059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
    Benedetti Panici P; Basile S; Maneschi F; Alberto Lissoni A; Signorelli M; Scambia G; Angioli R; Tateo S; Mangili G; Katsaros D; Garozzo G; Campagnutta E; Donadello N; Greggi S; Melpignano M; Raspagliesi F; Ragni N; Cormio G; Grassi R; Franchi M; Giannarelli D; Fossati R; Torri V; Amoroso M; Crocè C; Mangioni C
    J Natl Cancer Inst; 2008 Dec; 100(23):1707-16. PubMed ID: 19033573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.